Comparing Abreva vs Campho-Phenique
| Abreva (docosanol) | Campho-Phenique (camphor/phenol) |
|
|---|
| Abreva (docosanol) | Campho-Phenique (camphor/phenol) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Over-the-counter
Prescribed for Herpes Simplex (HSV). Abreva may also be used for purposes not listed in this medication guide. |
Over-the-counter
Campho-Phenique may also be used for purposes not listed in this medication guide. |
||||||||
| More about Abreva (docosanol) | More about Campho-Phenique (camphor/phenol) | ||||||||
| Ratings & Reviews | |||||||||
|
Abreva has an average rating of 4.5 out of 10 from a total of 426 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 56% reported a negative effect. |
Campho-Phenique has an average rating of 10.0 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Abreva side effects |
View all Campho-Phenique side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Abreva prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
||||||||
| Drug Interactions | |||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| First Approval Date | |||||||||
|
July 25, 2000 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
|
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.